Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013

Translational Medicine (EUSTM-2013)

14 Oct 2013 - 16 Oct 2013 - Mondorf-les-Bains, Luxembourg

Bookmark and Share

The Annual Congress of the European Society for Translational Medicine & Global Network Conference on Translational Medicine (EUSTM-2013) will be held in Mondorf-les-Bains, Luxembourg on October 14-16, 2013.It covers topics such as:

Personalized Medicine

Translational Research: Novel Findings and Updates in Pathophysiology and Diagnostics


Cell Therapy and Regenerative Medicine

Translational Bioinformatics & Data Management

Omics Sciences and Applications in Translational Research

Translational Pharmacology & Biobanking

Translational Medicine in Pre-clinical and Clinical Development and in the Post-Registration Phase

Public Health & Epidemiology in Translational Medicine

The Annual EUSTM-2013 Congress brings together attendees interested in translational medicine from

Research institutions

Academic centers


Regulatory agencies

Members of patient organizations

Practicing physicians

Medtech and medical instruments companies

Pharma and biotech industries

Clinical research organizations

Consultancy firms

Data management companies

EUSTM-2013 will bring together world leaders from the industry, academic centers, research institutions, regulatory agencies, and governments to discuss translational approaches and tools that will accelerate the research and development of novel diagnostics and therapeutics thereby reducing high cost budgets and attrition rates. Participants will also include practicing physicians with clinical experience in various therapeutic areas and members of patient organizations. EUSTM-2013 will offer an interdisciplinary forum to address current challenges in translational medicine and highlight novel solutions. The conference represents a unique opportunity for global networking. Pharma and biotech industries, medtech and medical instruments companies, consultancy firms, clinical research organizations and data management companies will showcase and exhibit their products and services.

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos